Integrated BioPharma's total assets for Q4 2024 were $26.21M, a decrease of -2.73% from the previous quarter. INBP total liabilities were $6.97M for the fiscal quarter, a -13.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.